APA (7th ed.) Citation

F, L., MJ, B., R, Z., C, G., OM, H., M, A., . . . C, I. (2021). Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. Cancer, 127(19), 3622. https://doi.org/10.1002/cncr.33620

Chicago Style (17th ed.) Citation

F, Lynce, et al. "Hematologic Safety of Palbociclib in Combination with Endocrine Therapy in Patients with Benign Ethnic Neutropenia and Advanced Breast Cancer." Cancer 127, no. 19 (2021): 3622. https://doi.org/10.1002/cncr.33620.

MLA (9th ed.) Citation

F, Lynce, et al. "Hematologic Safety of Palbociclib in Combination with Endocrine Therapy in Patients with Benign Ethnic Neutropenia and Advanced Breast Cancer." Cancer, vol. 127, no. 19, 2021, p. 3622, https://doi.org/10.1002/cncr.33620.